Is DOW a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on Chemical-cycle recovery, with revenue (ttm) at ~$41.3 billion. The bear case rests on the dominant risk is commodity-cycle cyclicality: Dow's plastics and chemicals sell into global markets at prices it does not control, so a prolonged downturn, weak industrial demand, or continued China-led oversupply can keep margins compressed and earnings in the red, as the losses from late 2025 through the first quarter of 2026 showed. Analysts covering it are spread from $29.00 to $41.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The dominant risk is commodity-cycle cyclicality: Dow's plastics and chemicals sell into global markets at prices it does not control, so a prolonged downturn, weak industrial demand, or continued China-led oversupply can keep margins compressed and earnings in the red, as the losses from late 2025 through the first quarter of 2026 showed. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $29.00, -3.1% from the $29.93 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

Chemical-cycle recovery. Dow's earnings are geared to the industrial chemical cycle, which spent 2025 and early 2026 near the bottom on weak demand and global oversupply. The most optimistic analyst target on DOW is $41.00, +37.0% from the $29.93 price. That figure is only reachable if this thesis works close to its best case.

The dominant risk is commodity-cycle cyclicality: Dow's plastics and chemicals sell into global markets at prices it does not control, so a prolonged downturn, weak industrial demand, or continued China-led oversupply can keep margins compressed and earnings in the red, as the losses from late 2025 through the first quarter of 2026 showed. The second-quarter 2026 rebound may not persist; consensus expects EPS to fall from about $1.44 in that quarter to about $0.64 in the third and about $0.46 in the fourth, and Goldman Sachs trimmed its price target to $31 from $33 in October. Feedstock and energy-cost swings cut margins directly, and tariffs and trade policy add cost volatility outside the company's control. The 2026 restructuring carries execution risk, and shuttering assets involves charges and disruption. The rebased dividend could face further pressure if cash flow stays weak, since trailing free cash flow covers only a fraction of it, and leverage (debt-to-equity above 110 percent) limits flexibility. Because results are tied to the cycle, a headline multiple can be misleading when it reflects depressed or temporarily elevated rather than normalized earnings. The most pessimistic published target is $29.00, -3.1% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

Dow Inc., through its subsidiaries, provides various materials science solutions for packaging, infrastructure, mobility, and consumer applications in the United States, Canada, Europe, the Middle East, Africa, India, the Asia.

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Chemical-cycle recovery) stalling in the reported numbers rather than in the narrative, the risk above (the dominant risk is commodity-cycle cyclicality: Dow's plastics and chemicals sell into global markets at prices it does not control, so a prolonged downturn, weak industrial demand, or continued China-led oversupply can keep margins compressed and earnings in the red, as the losses from late 2025 through the first quarter of 2026 showed) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

That depends on your goals, time horizon, and risk tolerance, and this is not investment advice. The bull case is a large, low-cost, integrated producer that has started to rebound, with a profitable second quarter of 2026, a restructuring plan, and a rebased dividend yielding about 4.7 percent. The bear case is that the cycle is still fragile: trailing earnings are a loss, analysts expect profits to shrink again in 2027, leverage is high, and the dividend exceeds earnings. Weigh both against your portfolio.

Dow is a materials-science company that turns oil-and-gas feedstocks into plastics, industrial chemicals, and specialty materials. It operates three segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings. Its products go into packaging, construction, coatings, electronics, mobility, and consumer goods, so results track global industrial demand rather than any single product.

In July 2025 Dow's board cut the quarterly dividend by 50% to $0.35 per share, an annual rate of about $1.40, in response to a prolonged industry downturn. The prior payout was running ahead of free cash flow while leverage sat above management's target. The cut was meant to protect the balance sheet and preserve cash through a weak chemicals market.